By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel's net takeaway is that Schwab's reliance on net interest margin (NIM) compression and potential risks from rate cuts, deposit beta, and funding costs make its 14x forward earnings multiple questionable, suggesting a value trap despite impressive asset growth.
Risk: NIM compression from potential rate cuts and deposit beta risk
Opportunity: None identified
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
We recently published Jim Cramer Discussed A Mysterious Yellow Light & These 9 Stocks. The Charles Schwab Corporation (NYSE:SCHW) is one the stocks discussed by Jim Cramer.
Banking giant The Charles Schwab Corporation (NYSE:SCHW)’s shares have been muted lately. They are up by 2.5% over the past year and are down by 10.5% year-to-date. Several analysts have discussed the bank as of late. For instance, UBS raised the share price target to $385 from $380 and kept a Buy rating on the shares on April 30th. Earlier, on the 20th, Argus had reduced the price target to $108 from $117 and kept a Buy rating on the stock. It outlined that The Charles Schwab Corporation (NYSE:SCHW)’s latest earnings results were quite impressive as the bank grew its revenue by 16% and its client assets to $11.8 trillion. Over the medium term, it outlined that it expects the bank to post growth higher than its peers. Cramer also discussed The Charles Schwab Corporation (NYSE:SCHW)’s share price performance:
“Now I think that Schwab has come down so much, that’s a very intriguing stock. Because it’s down 10% for the year, it’s down 14 times earnings.”
Image Credit: Pixabay
While we acknowledge the potential of SCHW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.** **
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"SCHW's depressed multiple already prices in the earnings risk from falling interest rates that Cramer and recent analyst notes largely overlook."
The article positions SCHW as attractive after a 10.5% YTD drop and 14x earnings multiple, citing 16% revenue growth and $11.8T client assets. Yet it ignores how much of that growth stems from elevated net interest income tied to higher rates. A series of Fed cuts would compress margins faster than asset inflows can offset, especially with competition from zero-fee brokers and money-market funds. UBS and Argus targets also diverge sharply ($385 vs $108), signaling uncertainty rather than consensus. The promo for an unrelated AI name further dilutes focus on SCHW-specific risks like regulatory capital rules and potential slowdown in retail trading volumes.
If rate cuts are delayed and equity markets rally sharply, SCHW could re-rate higher on asset inflows alone, making the current multiple look cheap rather than reflective of structural margin pressure.
"SCHW's valuation looks cheap only if earnings remain stable, but rate-sensitive brokerage margins face structural headwinds that the article completely ignores."
SCHW trades at 14x forward earnings after a 10.5% YTD decline, which looks cheap on surface. But the article conflates two separate signals: Argus cut its target from $117 to $108 (bearish), while UBS raised $380 to $385 (marginal). Revenue growth of 16% is solid, but the article omits net interest margin (NIM) trends—critical for brokerages in a high-rate environment. If the Fed cuts rates materially in H2 2024, SCHW's NIM compression could offset asset growth. The $11.8T in client assets is impressive but doesn't tell us about profitability per dollar managed.
Argus's downgrade within weeks of UBS's upgrade suggests analyst consensus is fragmenting, not converging—a red flag. Cramer's 'intrigued' framing is notoriously unreliable as a contrarian indicator.
"Schwab’s valuation is a value trap because sustained cash sorting and high deposit betas will continue to erode net interest margins regardless of headline asset growth."
Cramer’s focus on the 14x forward P/E ratio misses the critical structural headwind: Schwab’s reliance on net interest margin (NIM) compression. While $11.8 trillion in client assets is impressive, the 'cash sorting' phenomenon—where clients move idle cash into higher-yielding money market funds—continues to cannibalize Schwab's low-cost deposit base. This forces the firm to rely on costlier wholesale funding, suppressing net interest income. Unless the Fed initiates a sustained rate-cutting cycle to ease this funding pressure, the valuation might look 'cheap' at 14x, but it remains a value trap. The upside is capped until we see stabilization in deposit beta and a pivot in monetary policy.
If the yield curve steepens significantly, Schwab’s massive asset base could generate a massive tailwind for interest income that more than offsets the current deposit migration costs.
"SCHW's upside hinges on durable NII growth and asset inflows; without them, the multiple could compress despite an apparently cheap starting point."
Schwab looks undervalued on a narrative of stabilizing earnings and assets, with the article citing 16% revenue growth and $11.8T in client assets. The bullish setup relies on continued NII strength in a rising-rate regime and steady inflows into wealth and brokerage products. Yet the article glosses over meaningful risks: a potential reversal in rate expectations could compress net interest income, fee revenue could be pressured as assets migrate to cheaper platforms, funding costs may rise if deposits stall, and regulatory/compliance costs could erode margins. If growth cools or expenses rise, a 14x-like earnings multiple may fail to re-rate.
A rate pivot could crush NII, and Schwab faces stiff competition and potential outflows during volatility—any of which could derail the thesis.
"Persistent inflation could delay cuts and sustain Schwab's NII into 2025, softening the value-trap case."
The group fixates on near-term NIM compression from Fed cuts, but overlooks how sticky inflation could push rate relief into 2025, extending Schwab's net interest income tailwind. That delay would let the $11.8T asset base compound fees without immediate margin pressure, undermining Gemini's value-trap framing. If deposit betas also moderate faster than modeled under higher-for-longer policy, the 14x multiple starts to look more reasonable rather than deceptive.
"Higher-for-longer rates don't fix deposit beta damage already done; the group needs to isolate NII % of total revenue before claiming the valuation is reasonable."
Grok's 'higher-for-longer' scenario is plausible but sidesteps deposit beta risk. Even if rates stay elevated through 2025, Schwab's deposit costs have already risen—the lag isn't symmetric. Sticky deposits in 2024 don't reverse funding-cost inflation in 2025. Meanwhile, nobody has quantified how much of that 16% revenue growth is NII-dependent vs. fee-based. Without that split, we're debating shadows. The $11.8T asset base compounds fees only if Schwab keeps those assets—and cash-sorting pressure suggests otherwise.
"Schwab's valuation is suppressed by balance sheet duration risk and expensive supplemental funding, not just NIM sensitivity."
Claude is right to demand the NII-to-fee split, but you are all ignoring the balance sheet duration risk. Schwab’s held-to-maturity portfolio is still underwater, forcing them to carry expensive supplemental funding. Even if rates stay 'higher for longer,' they are trapped in a negative carry position on legacy assets. The 14x multiple isn't a discount; it’s a reflection of the capital required to fix their balance sheet liquidity before they can return to meaningful share buybacks.
"HTM balance-sheet constraints could cap upside even if NII benefits from higher rates."
Gemini’s bullish take on NII leverage misses a structural risk: Schwab’s legacy hold-to-maturity book can create sustained funding pressures and higher capital costs if rates stay high. HTM unrealized losses aren’t booked in earnings, but they constrain liquidity choices and drive more wholesale funding needs, dampening margin recovery even with asset inflows. If deposit beta improves slowly, this hidden balance-sheet constraint could cap upside, not just compress NIM.
The panel's net takeaway is that Schwab's reliance on net interest margin (NIM) compression and potential risks from rate cuts, deposit beta, and funding costs make its 14x forward earnings multiple questionable, suggesting a value trap despite impressive asset growth.
None identified
NIM compression from potential rate cuts and deposit beta risk